ArticleAmerican journal of preventive medicine2025
Heterogeneity in Nicotine, Tobacco, and Cannabis Use Among U.S. Adolescents and Adults Aged 12-34 Years.
Article in American journal of preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Co-Use of Some Substances Associated With Higher Doses in Adolescents: Findings From the Adolescent Brain Cognitive Development Study.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2026Article
- Documented Nicotine, Cannabis, and Co-Use Are Associated With More Intensive Emergency Department Care for Adolescent Asthma Exacerbations.Journal of the American College of Emergency Physicians open · 2026Article
- Identifying risk profile for adolescent e-cigarette use: A sex-stratified machine learning analysis.Drug and alcohol dependence reports · 2026Article
- Association Between E-Cigarette Use (Vaping) and Oral Health in Adolescents and Young Adults: A Systematic Review.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionNicotine, tobacco, and cannabis use continues to evolve in the U.S., with new forms of use (e.g., oral nicotine, cannabis edibles) emerging and increasing. It is critical to understand how these substances are being used and co-used. This study identified subgroups of adolescents and younger adults aged 12-34 years on the basis of nicotine, tobacco, and cannabis use using recent nationally representative data.
methodsCross-sectional data from the Population Assessment of Tobacco and Health Wave 7 (2022-2023) were used. Analyses focused on those aged 12-34 years who reported any past 30-day nicotine, tobacco, or cannabis use (n=8,722). Latent class analysis was conducted using 8 indicators: combustible tobacco use, nicotine vaping, oral nicotine product use, other noncombustible tobacco use (e.g., snus/chew), blunt use, cannabis smoking, cannabis vaping, and cannabis edibles. Differences were examined by sex, age, race, ethnicity, and region.
resultsOn average, individuals reported use of approximately 2 products in the past 30 days (mean=2.08). Six subgroups of nicotine, tobacco, and cannabis use were identified: combustible tobacco (30.77%), multimodal cannabis (26.72%), vaping nicotine (18.37%), multimodal co-use (13.87%), cannabis edibles (5.31%), and multimodal nicotine/tobacco (4.95%). Sociodemographic characteristics were associated with class membership.
conclusionsThere is substantial heterogeneity in nicotine, tobacco, and cannabis use among U.S. adolescents and younger adults. Of particular concern is that most of the sample reported combustible use, including 3 subgroups that reported multiple modes of use. Continued surveillance of nicotine, tobacco, and cannabis use is needed, particularly as the products and their regulation continue to evolve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.